The obtained data indicated that low doses of antineoplastic agents markedly promoted CD31+ and laminin+ tumor angiogenesis in vivo and inhibited the proliferation and viability of endothelial cells in vitro. The gene discussed is PECAM1; the disease is neoplasm.